A new class of weight-loss drugs is changing the food industry, but not in the way many expected at first. They could present ...

In Quebec, anti-obesity medications are on the list of exclusions of the Régie de l’assurance maladie du Québec (RAMQ). Quebec is the only Canadian province that does not evaluate obesity medications ...

ResMed stock broke out early Friday after the CPAP maker broadly beat third-quarter projections.Please watch the video at Investors.com - S&P 500 Giants Report Earnings. Will Megacap Results Sustain ...

Semaglutide outperformed 7 diabetes medications in reducing risk of Alzheimer's disease, according to a study of over 1 ...

GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according ...

Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of Alzheimer’s disease for certain groups, a new study finds.

Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...

The U.K. government issued a new warning aimed at the misuse of GLP-1 therapies by those who don’t qualify for the meds but are instead using them for quick-fix weight loss.

As the demand for weight loss injectables soars, so too does the market for off-brand alternatives, some of which may not be ...

Southwest Airlines settles with activist to end proxy fight, Novo Nordisk’s Ozempic might reduce Alzheimer’s risk, and more ...

Karan Johar's noticeable weight loss has sparked rumours about his possible use of Ozempic, a diabetes drug known for its ...

A new study found a link between NovoNordisk’s blockbuster drug Ozempic and a reduced risk of Alzheimer’s disease. 23andMe, ...